X0508 4 2025-12-17 0001133416 GALECTIN THERAPEUTICS INC GALT 0001557082 Shlevin Harold H. C/O GALECTIN THERAPEUTICS INC. 4960 PEACHTREE INDUSTRIAL BLVD., STE 240 NORCROSS GA 30071 true false false false true Common Stock 2025-12-17 4 M false 20000 1.98 A 31206 D Common Stock 2025-12-17 4 S false 19793 7.038 D 11206 D Common Stock 2025-12-17 4 S false 4706 7.038 D 6500 D Stock Option (right to buy) 1.98 2025-12-17 4 M false 20000 0 D 2022-12-31 2032-01-24 Common Stock 20000 0 D The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025, as disclosed in the Issuer?s Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025. The shares were sold in multiple transactions at prices ranging from $7.11 to $7.11. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. The options vested 100% on December 31, 2022.. Jack W. Callicutt, by power of attorney 2025-12-19